Results 111 to 120 of about 6,511 (194)

Cabergoline prevents weight gain in patients evaluated for hyperprolactinaemia

open access: yes, 2011
Introduction: Food reward stimuli elevate dopamine levels in brain reward circuits. Decreased dopaminergic signalling may be involved in pathophysiological processes leading to obesity and D2 receptor antagonists (antipsychotics) are associated with a ...
Aziz, R   +3 more
core  

Cabergoline (Velactis®) administration at dry-off enhances milk yield in subsequent lactation of Holstein and Girolando (Gir × Holstein) cows. [PDF]

open access: yesTrop Anim Health Prod
de Souza AH   +6 more
europepmc   +1 more source

Chinese consensus on the diagnosis and treatment of prolactinomas (2025 edition). [PDF]

open access: yesChin Neurosurg J
Lin S   +18 more
europepmc   +1 more source

Radiotherapy regimens and concurrent Cabergoline use for non-functioning pituitary neuroendocrine tumors: a large, single-center cohort. [PDF]

open access: yesEndocrine
Mauro GP   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy